Bioactive Compounds
-
B6062 Manumycin ASummary: farnesyltransferase inhibitor -
B1005 VilanterolSummary: β2-AR agonist -
B2210 Azilsartan2 CitationTarget: Angiotensin AT1 ReceptorsSummary: Potent angiotensin II type 1 (AT1) receptor inverse agonist -
B1035 Dolastatin 10Target: Microtubules/TubulinsSummary: Antitumor agent -
B2091 Doxercalciferol1 CitationTarget: Vitamin D receptors (VDRs)Summary: Vitamin D receptor activator -
B1092 Salicylic acidSummary: COX inhibitor -
B1400 Brefeldin A4 CitationSummary: ATPase inhibitor -
B2191 Dequalinium ChlorideTarget: PKC|Calcium-Activated Potassium (KCa) ChannelsSummary: anti-tumor agent and PKC inhibitor -
B1549 Hydroxyzine 2HClTarget: Histamine H1 ReceptorsSummary: Histamine H1-receptor antagonist -
B2274 Proparacaine HClTarget: Voltage-gated Sodium (NaV) ChannelsSummary: voltage-gated sodium channels antagonist
